Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs aimed toward increasing the horizons of cytokine-based immunotherapy, especially for cancers where remedy alternatives remain limited. Make use of the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Check https://financefeeds.com/21x-hires-victoria-jahn-as-head-of-regulatory-affairs/